TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery
TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round included both new and existing investors. Since its founding in October 2021, the company has raised over $80M. With a team of more than […]
TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery Read More »